PMDA posts MHLW notice on revising precautions for regenerative medical products (Jan 13, 2026)
使用上の注意の改訂指示通知（再生医療等製品）2026年1月13日付（厚生労働省より発出）を掲載しました
Published: 2026-01-13 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
PMDA's Safety Updates page lists a notice instructing revisions to the 'precautions for use' (package insert precautions) of regenerative medical products. The notice is described as issued by the Ministry of Health, Labour and Welfare (MHLW) and dated January 13, 2026. The provided metadata does not specify which products or what changes are involved.
Business Impact
Companies marketing regenerative medical products in Japan may need to check whether any of their products are covered and whether labeling changes could be required. The scope and any deadlines cannot be determined from the information provided.
Recommended Action
Review the official Japanese notice on the PMDA page to confirm which products are covered, what revisions are instructed, and any applicable timelines.